The wnt gene family encodes a secreted glycoprotein involved in the cell-cell signaling of a number of basic developmental processes from Caenorhabditis elegans to vertebrate (for reviews, see Refs. [1] [2] [3] . Genetic studies in Drosophila have identified and ordered several genes required for the Wingless (Wg) signaling (2) (3) (4) . wg (3, 4) activates dishevelled (dsh; Refs. 5 and 6) through a Wg receptor gene, Drosophila frizzled 2 (Dfz2; Ref. 7) . dsh in turn inhibits zeste-white3 (zw3; Refs. 8 and 9), which negatively regulates armadillo (arm; Refs. 10 and 11). Consequently, the Wg signal relieves this inhibitory function of zw3, resulting in the accumulation of the Arm protein. Arm then makes complex with Pangolin/Dtcf, and this complex translocates into the nucleus and regulates transcription of the Wg target genes (12) . The components of the Wg signaling pathway appear to be structurally and functionally well conserved in the Wnt pathway in vertebrate with Dvl proteins (13) (14) (15) (16) (17) (18) , glycogen synthase kinase-3␤ (GSK-3␤ 1 ; Refs. 19 and 20) , and ␤-catenin (21) being homologues of Dsh, ZW3, and Arm, respectively.
The dsh gene family encode cytoplasmic proteins that appear to serve as a scaffolding or adaptor protein, but their biochemical function in the Wnt/Wg signaling pathway is unknown. In mouse, three closely related dsh genes, Dvl-1, Dvl-2, and Dvl-3, have been isolated (13) (14) (15) (16) . There is 40 -50% amino acid identity between Drosophila dsh and each of the murine Dvl genes and 60% identity among murine Dvl genes. Murine Dvl genes are ubiquitously expressed during development, displaying extensive redundancy in spatial and temporal expression. All Dsh family members contain three highly conserved regions (Refs. 6, 13, 15, and 18; see Fig. 1 ): an N-terminal DIX domain, which is also found in the C terminus of Axin proteins (22) ; a PDZ domain found in several proteins involved in protein-protein interactions (PDZ domains can form dimers, and some PDZ domains but not that in Dsh can bind to the four-residue motif (X-(S/T)-X-V) at the C termini of proteins); and a DEP domain, which is conserved among a set of proteins that regulate various GTPases, including both heterotrimeric G proteins and Ras-like small GTPases. In Drosophila, dsh was also shown to function in the planar cell polarity signaling pathways. Genetic and molecular assay revealed that the DEP domain is dispensable for Wg signaling, but required for activation of c-Jun N-terminal kinase cascade during planar cell polarity signaling (23, 24) . In Drosophila cells, we have shown that Dsh is a phosphoprotein whose phosphorylation state is elevated either by stimulation with Wg, or overexpression of Dsh itself or Frizzled (6, (25) (26) (27) (28) . In addition, casein kinase II (CKII) was shown to associate with the PDZ domain of Dsh and phosphorylate it (28) . Although Dvl-1 null mutant mice have been generated (16) and Dvl-2 was shown to partially rescue the segmentation defects of Drosophila embryos devoid of dsh (14) , biochemical analysis of the mammalian Dvl proteins has been hampered by the lack of a soluble Wnt preparation that retains potent biological activities. However, recently, such a preparation of Wnt-3A has become available (29) .
In this study, we analyzed the biochemical properties of mouse Dvl proteins in the Wnt/Wg pathway, in comparison with those of Dsh protein. Similar to Wg in Drosophila, mouse Wnt-3A induces hyperphosphorylation of Dvl proteins and elevation of cytoplasmic ␤-catenin levels in mammalian cells. CKII was shown to coimmunoprecipitate with Dvl proteins, and Dvl proteins were phosphorylated in these immune complexes. Moreover, overexpression of Dvl-1 and Dvl-2 in Drosophila clone-8 wing disc cells led to elevation of Arm and DE-cadherin protein levels and inhibition of ZW3-mediated phosphorylation of transfected Tau protein. These results demonstrate the functional conservation of Dsh family proteins in Drosophila Wg and mouse Wnt pathways.
EXPERIMENTAL PROCEDURES
Expression Constructs-pMKDsh-Myc and pMKZW3-HA were described previously (6, 26) . The Myc epitope was added to the C termini of full-length mouse Dvl-1 or Dvl-2 proteins by using polymerase chain reactions (PCR) and pBSII-Myc plasmid (6) . The Dvl-1 and Dvl-2 sequences were amplified by PCR using pBluescript IISK plasmids containing the entire coding sequence of Dvl-1 or Dvl-2 (gifts from D. Sussman) as templates and the following set of sense primers containing initiator ATG and EcoRI sites and antisense primers containing EcoRI sites: for Dvl-1, a 27-base sense primer (5Ј-GTAGAATTCGCCAT-GGCGGAGACCAAA-3Ј) and a 27-base antisense primer (5Ј-CCCGAA-TTCCATGATGTCCACAAAGAA-3Ј); for Dvl-2, a 23-base sense primer (5Ј-CCGGAATTCACCATGGCGGGCAG-3Ј) and a 27-base antisense primer (5Ј-AAGGAATTCTGGGTTATAGGGGAGAGC-3Ј). The Dvl-1 and the Dvl-2 PCR products were digested with EcoRI and subcloned into the EcoRI site of the pBSII-Myc. The resulting plasmids were named pBSDvl-1-Myc and pBSDvl-2-Myc, respectively. To generate a plasmid expressing Myc-tagged Dvl-1 (named pMKDvl-1-Myc) and Myc-tagged Dvl-2 (named pMKDvl-2-Myc), the 2.1-kb XbaI-SalI fragment of pBSDvl-1-Myc and the 2.2-kb KpnI-BamHI fragment of pBSDvl-2-Myc, respectively, were blunted with T4 polymerase (Takara) and cloned into the EcoRV site of pMK33 (30) . pUAST-Tau, a plasmid that expresses Tau under the control of a UAS promoter, was constructed by inserting a 2.0-kb EcoRI fragment of pSG5 Tau plasmid (a gift from C. C. J. Miller; Ref. 31) encoding Tau cDNA, into the EcoRI site of pUAST (32) . For Tau expression, pRK-245 (32), a plasmid expressing GAL4 protein under the control of the actin 5C promoter, was used in combination with pUAST-Tau. The fidelity of the PCR reactions was confirmed by DNA sequencing.
Cell Cultures, Transfections, and Cell Fractionation-NIH3T3, C57MG, and L cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. The Wnt-3A-producing L cells (transfected with pGKWnt-3A) and control L cells (transfected with pGKNeo) were maintained in the presence of G418 as described (29) . The Drosophila wing imaginal disc cell line, clone-8, was cultured as described (6) . Expression plasmids were transfected into clone-8 cells using the calcium phosphate method as described (26) . The pMKDshMyc, the pMKDvl-1-Myc, and the pMKDvl-2-Myc transfectants used in this study were mixtures of stable clone-8 cell clones selected with hygromycin (200 M) and were named Clone-8/Dsh, Clone-8/Dvl-1, and Clone-8/Dvl-2, respectively. The transfectants generated with pMK33-based vectors were induced to overexpress the transfected genes by adding 0.5 mM CuSO 4 as described (6) . Confluent cultures of NIH3T3 and C57MG cells in T75 flasks incubated in Wnt-3A-conditioned medium (CM) or Con-CM for 3 h were harvested, and the collected cells were subjected to cell fractionation as described (26) . The cytoplasmic and the membrane fractions were subjected to Western blotting with anti-␤-catenin antibody.
Wnt-3A Assay-The CM was prepared from Wnt-3A-producing L cells (Wnt-3A-CM) and control L cells (Con-CM) as described (29) . The NIH3T3, L, or C57MG cells were allowed to grow until confluent, the culture medium was replaced with Wnt-3A-CM or Con-CM. After incubation in the CM for various periods of time, the cell extracts for SDS-PAGE were prepared as described (6) .
Immunoblot Analyses and Antibodies-The cell lysates whose protein concentration was normalized were subjected to Western blot analysis as described (6, 26) . The antibodies used for the analysis included the mouse monoclonal anti-Arm antibody N2-7A1 (33), the rat polyclonal anti-Dsh region I antibody (6), the mouse monoclonal antiDvl-1 antibody (a gift from D. J. Sussman; Ref. 16) , the rabbit polyclonal anti-human Dvl-2 antibody (a gift from M. Snyder; Ref. 18) , the mouse monoclonal anti-␤-catenin antibody (Transduction Laboratories), the Tau antibody that recognizes all forms of Tau (clone T14, Zymed Laboratories Inc.), the mouse monoclonal antibody specific for the phosphorylated form of Tau (anti-hPHF Tau antibody, AT8, Innogenetics), the mouse monoclonal anti-GSK-3␤ antibody (Transduction Laboratories), the mouse monoclonal anti-HA antibody 12CA5 (Roche Molecular Biochemicals), the rabbit polyclonal anti-CKII antibody (gift from C. V. C. Glover; Ref. 34) , the mouse monoclonal anti-human c-Myc antibody 9E10 (Oncogene Science), the rat monoclonal anti-Drosophila E-cadherin (DE-cadherin) antibody DCAD-2 (35), the rat monoclonal antiDrosophila ␣-catenin antibody DCAT-1 (36), and peroxidase-conjugated secondary antibodies against mouse IgG (Bio-Rad), rat IgG (Jackson Immunoresearch Laboratory), and rabbit IgG (Cappel). The blots were visualized with the enhanced chemiluminescence reagent (Amersham Pharmacia Biotech). The anti-mouse Dvl-1 and the anti-human Dvl-2 antibody were raised against an unique sequence in each protein, and thus specifically recognize their respective Dvl proteins.
Immunofluorescence Analysis-Clone-8/Dvl-1 or Clone-8/Dvl-2 was seeded in four-well chamber slides (Nalge Nunc) and treated with CuSO 4 for 24 h. The clones were fixed, permeabilized, and blocked as described (26) . The samples were processed for indirect immunostaining with the mouse monoclonal anti-Myc antibody followed by fluorescein isothiocyanate-conjugated rabbit anti-mouse immunoglobulins (Dako). The samples were mounted in Vectashield medium (Vector Laboratories) and observed using a Bio-Rad confocal laser setup (MRC 600) attached to a Zeiss Axioscope microscope.
Immunoprecipitation, Phosphatase Treatment, and Kinase AssayThe cell lysates for immunoprecipitation were prepared as described (6) . Twenty l of anti-Myc antibody (9E10) was added to the cell lysate and the mixture incubated overnight at 4°C, after which 30 l of goat anti-mouse IgG (HϩL)-Sepharose 4B (Zymed Laboratories Inc.) was added and the mixture incubated for another 1 h at 4 C. The immune complexes were washed four times with lysis buffer and resuspended in SDS-PAGE sample buffer and boiled. The phosphatase treatment of these Dvl-immune complexes was performed as described (18) . Dvl-1 protein was immunoprecipitated with anti-Dvl-1 antibody from lysates of NIH3T3 cells stimulated with Wnt-3A-CM or Con-CM for 3 h. The immunoprecipitates were treated with or without phosphatase and then subjected to SDS-PAGE. In vitro kinase assay for Dsh-or Dvlassociated kinase was performed as described (28) (6, 27) . Therefore, we analyzed the biochemical changes induced by mouse Wnt-3A signaling in mammalian cells. As a first step, the protein levels and modification status of Dvl proteins, ␤-catenin, and GSK-3␤ proteins were compared between mouse cells treated with Wnt-3A-CM or with Con-CM (Figs. 2 and 3 ). In addition to antibodies against Dvl-1 and Dvl-2, rat polyclonal antibody against the DIX domain of Drosophila Dsh (6) was used for these analyses, because this antibody was found to cross-react with both Dvl-1 and Dvl-2 (see Fig. 5 ; cross-reactivity with Dvl-3 was not analyzed). Immunoblots of total lysates from NIH3T3 cells treated with either Con-CM or Wnt-3A-CM demonstrated that two Dvl bands of 90 kDa ( Fig. 2A, arrow) and 95 kDa ( Fig. 2A , arrowhead) were detected with anti-Dsh. Similar to Wg in Drosophila cells (6), Wnt-3A induced a marked increase of the 95-kDa band in expense of the 90-kDa band ( Fig. 2A, lanes 1-6) . The anti-Dsh blot ( Fig. 2A, lanes 1 and 2) may represent the sum of the modifications that occurred in Dvl-1, Dvl-2 and probably Dvl-3 proteins, because both Dvl-1 and Dvl-2 were modified upon Wnt-3A treatment ( Fig. 2A, lanes 3-6) . In contrast, profiles of the GSK-3␤ protein (detected as two bands) were not affected by Wnt-3A treatment ( Fig. 2A, lanes 9 and 10) . On the other hand, we reproducibly detected a slight increase in the total ␤-catenin level in NIH3T3 cells upon Wnt-3A treatment ( Fig. 2A, lanes 7 and 8) . In NIH3T3 cells, significant pools of ␤-catenin, as a cadherin-associated form, were constitutively present in the plasma membrane fraction, which makes it difficult to detect the Wnt-3A-induced elevation of cytoplasmic ␤-catenin. Therefore, NIH3T3 cells harvested at various times after addition of Wnt-3A CM were fractionated into cytoplasmic and membrane-associated fractions, and the levels of ␤-catenin in both fractions were analyzed together with the levels and modified status of Dvl proteins in the total lysate (Fig. 2B) . While the amount of membrane-associated ␤-catenin was not affected by Wnt-3A, cytoplasmic ␤-catenin levels increased and the modification of Dvl proteins progressed with similar kinetics after addition of Wnt-3A (for example, elevation of the cytoplasmic ␤-catenin level and modification of Dvl proteins occurred 0.5 h, and plateaued between 3 and 6 h, after Wnt-3A treatment), suggesting that these two events are well connected in Wnt signaling. phosphorylation (6, (25) (26) (27) . To confirm that the Dvl proteins are indeed phosphorylated upon Wnt-3A treatment, Dvl-1 was immunoprecipitated from cell lysates of NIH3T3 cells treated with Wnt-3A-CM or Con-CM and was incubated with phosphatase (Fig. 2C) . Treatment with phosphatase converted the slowly migrating band to a band with good mobility, demonstrating that the phosphorylation caused a mobility shift of Dvl proteins on SDS-PAGE.
Next, the same experiments were performed with L and C57MG cells (Fig. 3) , both of which have been used for the analyses of biochemical changes and cell transformations induced by Wnts (29, 37, 38) . Consistent with the observation in NIH3T3 cells, Wnt-3A induced modification of Dvl proteins (Fig. 3, A and B, top panels) and elevation of the cytoplasmic ␤-catenin level in both of these cell lines (Fig. 3, A and B,  middle panels) . In L cells, total ␤-catenin levels were markedly elevated in response to Wnt-3A (Fig. 3A, middle panel) . This is due to the fact that naive L cells lack cadherin expression and thus have little ␤-catenin protein (29) . Compared with NIH3T3 ( Fig. 2A ) and C57MG cells (Fig. 3B, top panel) , however, much less Dvl protein was modified (Fig. 3A, top panel) upon Wnt-3A treatment in L cells. Wnt-3A has no effect on the steady state levels and modification status of GSK-3␤ in L cells, just like in NIH3T3 cells (Fig. 3A, bottom panel) . These results suggest that hyperphosphorylation of Dvl proteins is commonly induced in response to Wnt-3A in a variety of cells, although the profiles and the levels of phosphorylation of Dvl proteins differ from cell line to cell line. Thompson et al. (42) . These results suggested that persistent expression of Dvl proteins may be harmful to mammalian cells. To circumvent this problem, a Drosophila clone-8 cell that stably overexpresses Dvl-1 or Dvl-2 was established and the consequences of overexpression of Dvl proteins were studied, since we have shown that overexpression of Dsh in clone-8 cells results in marked accumulation of Arm and concomitant induction of DE-cadherin (6, 26) . Indirect immunofluorescence stainings of Clone-8/Dvl-1 and Clone-8/Dvl-2 indicated that overexpressed Myc-tagged Dvl-1 and Dvl-2 proteins localized mainly in the cytoplasm (Fig. 4) . In addition, intense dotlike stainings associated with the plasma membrane were frequently observed especially in Clone-8/Dvl-2 cells (Fig. 4C) . Next, the effects of Dvl-1 or Dvl-2 overexpression on Arm, DE-cadherin, and D␣-catenin protein levels were examined (Fig. 5) . The Dvl-1 or Dvl-2 induction kinetics demonstrated that the metallothionein promoter can induce much higher levels of Dvl-1 or Dvl-2 (Fig. 5, arrow and arrowhead in the panels in the second row) than of endogenous Dsh (Fig. 5 , open arrowhead in the panels in the second row). The slower migrating forms of Dvl protein (Fig. 5 , arrowhead in the panels in the second row) appeared as accumulation of Dvl protein proceeded. Concomitant with this, Arm protein levels were markedly elevated. The accumulation of DE-cadherin was also detected but to a much lesser extent (Fig. 5, panels in the fourth row) . In contrast, D␣-catenin levels were not affected by overexpression of Dvl proteins (Fig. 5, panels in the fifth row) . In addition to clone-8 cells, Dvl-1 or Dvl-2 overexpression elevated Arm protein levels in other Drosophila cells, Schneider S2 and S2Rϩ (27) cells (data not shown). Klingensmith et al. (14) have reported that in an in vivo study Dvl-2 but not Dvl-1 partially rescued the segmentation defects of Drosophila embryos devoid of dsh. However, in our cell culture system, overexpression of Dvl-1 and Dvl-2 both led to an increase in Arm levels.
Overexpression of Dvl-1 or Dvl-2 Protein Leads to Elevation of Arm and DE-cadherin Protein Levels in Clone-8 Cells-To
CKII Is Associated with and Phosphorylates Dsh, Dvl-1, or Dvl-2 in Clone-8 Cells-Next, we checked whether increasing shifts in the mobility of Dvl-1 or Dvl-2 proteins, which occurred concomitantly with overexpression of the Dvl proteins themselves (Fig. 5) , are indeed due to phosphorylation. The overexpressed Dvl-1 and Dvl-2 proteins were immunoprecipitated and treated with or without phosphatase, then subjected to Western blot analysis with anti-Myc antibody. The slow migrating Dvl species observed in Clone-8/Dvl-1 and Clone-8/ Dvl-2 cells induced with CuSO 4 for 24 h disappeared upon phosphatase treatment, indicating that the modification of Dvl proteins induced by overexpression of Dvl proteins themselves is the phosphorylation (Fig. 6A) . Willert et al. have reported that CKII binds to and phosphorylates the PDZ domain of Dsh (28) . Therefore, in vitro kinase reactions were performed using labeled ATP and the Dsh, Dvl-1, and Dvl-2 immunoprecipitates obtained with anti-Myc antibody (Fig. 6B) . These analyses demonstrated that the major phosphorylated protein produced in each in vitro kinase reaction corresponds to each Dsh or Dvl protein (compare the top and bottom panels in Fig. 6B ). To further confirm that CKII indeed associated with Dsh, Dvl-1, and Dvl-2, the immunoprecipitates obtained with anti-Myc antibody were subjected to Western blot analysis with an antibody against Drosophila CKII. As expected, the CKII ␣ subunit (38 kDa) co-immunoprecipitated with Dsh, Dvl-1, and Dvl-2 (Fig. 6B, middle panel) . However, because the comigration of the immunoglobulins, we could not show the co-immunoprecipitation of the CKII ␤ subunit (28 kDa) in this blot. Although we have not proven that CKII is the Dsh-or Dvl-phosphorylating kinase, we have shown that a kinase makes a complex with and phosphorylates Dsh or Dvl proteins and that CKII is a kinase present in these complexes.
Overexpression of Dsh, Dvl-1, or Dvl-2 Inhibits ZW3-mediated Phosphorylation of Tau in Vivo-We showed that Dvl-1 or Dvl-2 overexpression elevates the Arm protein levels (Fig. 5) .
The epistatic analysis of the Wg pathway suggests that overexpressed Dvl-1 or Dvl-2 inhibits ZW3, which in turn causes the Arm protein level to elevate. To directly evaluate Dsh-, Dvl-1-, or Dvl-2-induced modulation of ZW3 activities, we modified and utilized an in vivo assay for GSK-3␤ that uses the microtubule-binding protein, Tau, another good substrate for GSK-3␤ (30, 39) , because Drosophila ZW3 has been shown to be replaceable with rat GSK-3␤ (8) . With the anti-Tau antibody that recognizes all forms of Tau, the transfected Tau protein was detected as an apparently broad band, which actually consists of several species of Tau that have different mobilities (Fig. 7, third panel, second through sixth lanes) . This blot and the anti-HA blot (Fig. 7, second panel) also indicated that almost the same amount of Tau or HA-tagged ZW3 proteins were expressed in clone-8 and these Dsh or Dvl transfectants. With the antibody specific for the phosphorylated form of Tau, however, no band was detected in clone-8 cells only transfected with a Tau-expressing plasmid, pUAST-Tau, in combination with pRK245, suggesting that endogenous ZW3 kinase activity in clone-8 cell is too low to produce detectable amounts of phosphorylated Tau (Fig. 7, fourth panel, second lane) . Therefore, the plasmid expressing HA-tagged ZW3 (pMKZW3-HA) and the pUAST-Tau plasmid were cotransfected into these cells (Fig. 7, third through sixth lanes in all panels) and, in this condition, the effect of Dsh, Dvl-1, and Dvl-2 overexpression on the levels of the phosphorylated form of Tau were analyzed (Fig. 7, fourth panel) . As expected, co-transfection of ZW3 with Tau induced the phosphorylation of Tau in clone-8 cells (Fig. 7,  fourth panel, third lane) . However, despite the expression of the same amount of Tau and ZW3 protein (Fig. 7, third panel) , no phosphorylated form of Tau was detectable in Clone-8/Dsh, Clone-8/Dvl-1, and Clone-8/Dvl-2 cells (Fig. 7 , fourth panel, fourth through sixth lanes), indicating that overexpressed Dsh, Dvl-1, or Dvl-2 inhibited ZW3-mediated phosphorylation of Tau. The simplest explanation for this is that overexpressed Dsh, Dvl-1, or Dvl-2 inhibited ZW3 kinase activity by an unknown mechanism, although we could not exclude the possibil- (18) made a similar observation in several human cell lines and embryonic tissues. In this regard, the Schneider S2 cell line lacking Fz and Dfz2 expression has a single band of unphosphorylated Dsh, whereas ectopic expression of Frizzled protein in this cell line led to generation of several phosphorylated forms of Dsh (6, 27, 28, 40) . Thus, the difference of Dsh phosphorylation profiles between cell types may at least partly be caused by differences in the expression of Frizzled family proteins.
Both Wnt-3A and Wg induce phosphorylation of Dvl and Dsh, and elevation of ␤-catenin and Arm levels, respectively. In addition, the overexpression of Dsh family proteins, which leads to elevation of the Arm level, is always accompanied by the phosphorylation of these proteins, and an association of CKII with Dsh family proteins was demonstrated. These results support the idea that hyperphosphorylation of Dvls/Dsh and the kinase(s) responsible for this phosphorylation are integral parts of the Wnt/Wg signaling pathway. However, over- expression of Dfz2 or mouse Fz6 induces high levels of Dsh phosphorylation but does not lead to Arm accumulation (27, 28) , indicating that the Dsh or Dvl phosphorylation induced by expression of Frizzled family proteins is not sufficient for transduction of the Wnt/Wg signal. Therefore, we speculate that the Dvl/Dsh phosphorylation induced by Wnt/Wg treatment or Dvl/ Dsh overexpression is functionally different from that induced by the expression of Frizzled. In addition to CKII, the participation of protein kinase C in Dvl/Dsh phosphorylation is also suspected because of the following findings; the cDNA sequence of a protein kinase C-binding protein, RACK8 (GenBank accession number U48252) is nearly identical to that of a portion of human Dvl-3 from the PDZ domain to C terminus. In addition, Cook et al. have reported in mouse 10T1/2 fibroblasts that Wg inactivates GSK-3␤ via an intracellular signaling pathway that involves a protein kinase C (41). Phosphorylation of Dsh family proteins is one of the major and well conserved biochemical changes associated with activation of Wnt/Wg signaling. However, the functional significance of Dsh or Dvl phosphorylation is not established, and clearly additional experiments are necessary.
